![Frontiers | Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update | Cardiovascular Medicine Frontiers | Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update | Cardiovascular Medicine](https://www.frontiersin.org/files/Articles/660986/fcvm-08-660986-HTML/image_m/fcvm-08-660986-g001.jpg)
Frontiers | Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update | Cardiovascular Medicine
![Effectiveness of Only Aspirin or Clopidogrel Following Percutaneous Left Atrial Appendage Closure - American Journal of Cardiology Effectiveness of Only Aspirin or Clopidogrel Following Percutaneous Left Atrial Appendage Closure - American Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/325d171f-2a88-4ca4-84d2-2e6ecab3baaf/gr1.jpg)
Effectiveness of Only Aspirin or Clopidogrel Following Percutaneous Left Atrial Appendage Closure - American Journal of Cardiology
![Oral anticoagulant therapy in adults with congenital heart disease and atrial arrhythmias: Implementation of guidelines - International Journal of Cardiology Oral anticoagulant therapy in adults with congenital heart disease and atrial arrhythmias: Implementation of guidelines - International Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/bb4828d2-7f4b-4ece-9021-da244efd4939/gr1_lrg.jpg)
Oral anticoagulant therapy in adults with congenital heart disease and atrial arrhythmias: Implementation of guidelines - International Journal of Cardiology
![Management of atrial fibrillation breakthrough with rapid ventricular... | Download Scientific Diagram Management of atrial fibrillation breakthrough with rapid ventricular... | Download Scientific Diagram](https://www.researchgate.net/publication/289555155/figure/fig1/AS:411360715395077@1475087445879/Management-of-atrial-fibrillation-breakthrough-with-rapid-ventricular-response-AAD.png)
Management of atrial fibrillation breakthrough with rapid ventricular... | Download Scientific Diagram
![Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin | Stroke Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin | Stroke](https://www.ahajournals.org/cms/asset/ae1d4f62-1d89-45e6-a77e-177b70848cd3/3291fig03.jpeg)
Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin | Stroke
![References in Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study - Heart Rhythm References in Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study - Heart Rhythm](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7885a13c-e9f2-4c9c-b6f1-d66427faa7d4/gr1_lrg.jpg)
References in Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study - Heart Rhythm
![Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial - The Lancet Neurology Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/11064ab7-590c-4e3c-bf44-87df147d66be/gr1_lrg.jpg)
Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial - The Lancet Neurology
![The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation - Canadian Journal of Cardiology The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation - Canadian Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ffe41748-db76-4cf1-8891-0e2e5a7fa78f/gr1_lrg.jpg)
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation - Canadian Journal of Cardiology
![Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial - The Lancet Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2000990157/2003648134/gr1.gif)
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial - The Lancet
![References in Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study - Heart Rhythm References in Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study - Heart Rhythm](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8a0aa113-6f1f-442e-b028-2c62a6f40125/gr1.jpg)
References in Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study - Heart Rhythm
![Low-Dose Aspirin in Heart Failure Not Complicated by Atrial Fibrillation: A Nationwide Propensity-Matched Study - ScienceDirect Low-Dose Aspirin in Heart Failure Not Complicated by Atrial Fibrillation: A Nationwide Propensity-Matched Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213177917306844-fx1.jpg)